Landscapes / Targets
PKC
5 drugs act on PKC, in 11 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Kinase inhibitor |
Approved | 18 May 2029Phase 2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 18 May 2029 · Phase 2 trial completes | ||||
| Also tested for | FLT3-mutated Acute Myeloid Leukemia | ||||
| Open drug page | |||||
— |
Phase 3 | 15 Jan 2027Phase 2/3 trial completes | |||
| Next date | 15 Jan 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Uveal Melanoma, Metastatic Uveal Melanoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 2 | Jan 2027Phase 2 trial completes | |||
| Next date | Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Head and Neck Cancer, Soft Tissue Sarcoma | ||||
| Open drug page | |||||
— |
Phase 1/2 | Sep 2028Phase 1/2 trial completes | |||
| Next date | Sep 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Diabetic Macular Edema, Macular Edema and 5 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 May 2027Phase 1 trial completes | |||
| Next date | 30 May 2027 · Phase 1 trial completes | ||||
| Also tested for | Type 2 diabetes | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026